يعرض 1 - 20 نتائج من 204 نتيجة بحث عن '"Tokgözoglu L."', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: The Familial Hypercholesterolaemia Network Rochester, UK (FH Europe), University of Amsterdam Amsterdam = Universiteit van Amsterdam (UvA), University Medical Centre Ljubljana Ljubljana, Slovenia (UMCL), Masaryk University Brno (MUNI), Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Hôpital Femme Mère Enfant CHU - HCL (HFME), Hospices Civils de Lyon (HCL), Imperial College London, Universidade de São Paulo = University of São Paulo (USP), Technische Universität Munchen - Technical University Munich - Université Technique de Munich (TUM), Hacettepe University = Hacettepe Üniversitesi, Basque Foundation for Health Innovation and Research Barakaldo, Spain (BIOEF), Universidade de Lisboa = University of Lisbon = Université de Lisbonne (ULISBOA)

    المصدر: ISSN: 2047-4873.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/36059237; inserm-03833176; https://inserm.hal.science/inserm-03833176; https://inserm.hal.science/inserm-03833176/document; https://inserm.hal.science/inserm-03833176/file/zwac200.pdf; PUBMED: 36059237; WOS: 000860847200001

  2. 2
    Academic Journal

    المصدر: GMS Health Innovation and Technologies; VOL: 16; DOC04 /20220930/

    Relation: Ademi Z, Norman R, Pang J, Liew D, Zoungas S, Sijbrands E, et al. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment? Atherosclerosis. 2020;304:18. DOI:10.1016/j.atherosclerosis.2020.05.007; Cuchel M, McGowan MP. Familial hypercholesterolaemia: too many lost opportunities. The Lancet. 2021;398(10312):166-78. DOI:10.1016/S0140-6736(21)01372-6; EURORDIS. Czech Deputy Health Minister calls for a European Union Action Plan on rare diseases, as Czechia takes over the EU Presidency. 2022 Jul 1 [cited 2022 Sep 13]. Available from: https://www.eurordis.org/press-release-ecrd-cz-presidency/; European Atherosclerosis Society. Lipid Clinics Network. [cited 2022 Sep 13]. Available from: https://www.eas-society.org/page/lcn_main; European Commission. Proceedings of the Webinar Healthier together: EU non-communicable diseases initiative. 2022 Jun 22 [cited 2022 Sep 13]. Available from: https://health.ec.europa.eu/events/healthier-together-eu-non-communicable-diseases-initiative-2022-06-22_en; European Commission Public Health Best Practice Portal. Selection of best practices in non-communicable disease prevention: Paediatric screening of FH (Familial Hypercholesterolaemia) patients. 2021 [cited 2022 Sep 13]. Available from: https://webgate.ec.europa.eu/dyna/bp-portal/practice.cfm?id=390; Familial Hypercholesterolaemia Australasia Network. The National Familial Hypercholesterolaemia Registry. [cited 2022 Sep 13]. Available from: https://fhregistry-international.com/; Gidding SS, Wiegman A, Groselj U, Freiberger T, Peretti N, Dharmayat KI, et al. Paediatric familial hypercholesterolaemia screening in Europe - Public background and recommendations. Eur J Prev Cardiol. 2022:200. DOI:10.1093/eurjpc/zwac200; Groselj U, Wiegman A, Gidding SS. Screening in children for familial hypercholesterolaemia: start now. Eur Heart J. 2022;22-4. DOI:10.1093/eurheartj/ehac224; Kerr M, Pears R, Miedzybrodzka Z, Haralambos K, Cather M, Watson M, et al. Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK. Eur Heart J. 2017;38(23):1832-9. DOI:10.1093/eurheartj/ehx111; McKay AJ, Hogan H, Humphries SE, Marks D, Ray KK, Miners A. Universal screening at age 12 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis. Atherosclerosis. 2018;275:434-43. DOI:10.1016/j.atherosclerosis.2018.05.047; The Council of the European Union. Council conclusions on personalised medicine for patients, 2015/C 421/03. 2015 Dec 17 [cited 2022 Sep 13]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52015XG1217(01)&from=FR; WHO Human Genetics Programme. Familial hypercholesterolaemia (FH): report of a second WHO consultation, Geneva, 4 September 1998. Geneva: World Health Organization; 1999 [cited 2022 Sep 13]. Available from: https://apps.who.int/iris/handle/10665/66346.; Wilemon KA, Patel J, Aguilar-Salinas C, Ahmed CD, Alkhnifsawi M, et al. Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action. JAMA Cardiol. 2020;5(2):217. DOI:10.1001/jamacardio.2019.5173; World Heart Federation. Improving prevention and control of raised cholesterol: a call to action World Heart federation White Paper. Geneva: World Heart Federation; 2021 [cited 2022 Sep 13]. Available from: https://world-heart-federation.org/resource/whf-cholesterol-white-paper/; http://dx.doi.org/10.3205/hta000136; http://nbn-resolving.de/urn:nbn:de:0183-hta0001369; http://www.egms.de/en/journals/hta/2022-16/hta000136.shtml

  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
  7. 7
    Academic Journal
  8. 8
    Academic Journal

    Relation: Eur J Prev Cardiol . 2019;26(8):824-835.; http://hdl.handle.net/10400.17/4474

  9. 9
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
  17. 17
  18. 18
    Academic Journal

    المساهمون: Pfizer Incorporated, European Atherosclerosis Society

    المصدر: 255 ; 234

  19. 19
    Academic Journal

    المصدر: 2539 ; 2526

    جغرافية الموضوع: England

  20. 20